Titlebook: Breast Cancer; Nuclear Medicine in Emilio Bombardieri,Luca Gianni,Gianni Bonadonna (C Book 2008 Springer-Verlag Berlin Heidelberg 2008 Bre

微枝末節(jié)

細(xì)胞

Progress in the Treatment of Early and Advanced Breast Cancer,appropriate postoperative treatments. Nodal status, tumor size, tumor grade, age and HER2 expression are universally accepted as important factors to define risk categories. Newer factors such as uPA/PAI-1, cyclin-E and other proliferative indices and the gene expression profile are promising and wi

華而不實(shí)

Overview: Brings up-to-date nuclear medical knowledge in breast cancer.Information on the advances in the field of diagnosis.Data on the development of some new modalities.General overview of the available tool978-3-642-07186-7978-3-540-36781-9

空洞

Die Berücksichtigung von Verm?genseffekteno study breast tumours. Besides the different options among the imaging modalities, other aspects are overviewed including the biology and histology of breast cancer as well as the available laboratory tests and treatments. One chapter is dedicated to the histological classification of breast cancer

小木槌

EXCEL

,Einige elementare überlegungen, treatment modalities that are effective in the presence of favourable clinical or patho-biologic features, there is still a great deal of controversy in its clinical management. In the last decades, tumour biomarkers that are indicative of or related to cell traits characterising malignancy, such a

crescendo

Volkswirtschaftliche Gesamtrechnung,urrently used in clinical practice. Serum marker levels reflect tumour burden, and for this reason they are not sensitive enough to be used for screening and early diagnosis of primary breast cancer. By contrast, the role of tumour markers is established in the diagnosis of recurrent disease and in

無(wú)動(dòng)于衷

Nausea

Internationale Wirtschaftsbeziehungen,he female population. It is the second leading cause of death for women following lung cancer, accounting for 15% of all cancer deaths among women in the USA. In 2005, the American Cancer Society estimated 211,240 new cases and 40,410 female deaths from this disease (Jemal et al. 2005). Trends in in

Cursory